256 related articles for article (PubMed ID: 27153502)
1. A survey of the assessment and management of gout in general practitioners and medical officers within the Illawarra Network, Australia.
Terrill M; Riordan J
Int J Rheum Dis; 2017 Aug; 20(8):990-995. PubMed ID: 27153502
[TBL] [Abstract][Full Text] [Related]
2. A survey on the beliefs and knowledge of gout management in new medical graduates - New South Wales, Australia.
Terrill M; Riordan J
Int J Rheum Dis; 2018 Feb; 21(2):517-522. PubMed ID: 28544467
[TBL] [Abstract][Full Text] [Related]
3. Current gout treatment and flare in South Korea: Prophylactic duration associated with fewer gout flares.
Choi HJ; Lee CH; Lee JH; Yoon BY; Kim HA; Suh CH; Choi ST; Song JS; Joo HY; Choi SJ; Lee JS; Shin KC; Baek HJ
Int J Rheum Dis; 2017 Apr; 20(4):497-503. PubMed ID: 25160939
[TBL] [Abstract][Full Text] [Related]
4. Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients.
Janssen CA; Jansen TLTA; Oude Voshaar MAH; Vonkeman HE; van de Laar MAFJ
Rheumatol Int; 2017 Sep; 37(9):1435-1440. PubMed ID: 28748426
[TBL] [Abstract][Full Text] [Related]
5. Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire.
Harrold LR; Mazor KM; Negron A; Ogarek J; Firneno C; Yood RA
Rheumatology (Oxford); 2013 Sep; 52(9):1623-9. PubMed ID: 23620554
[TBL] [Abstract][Full Text] [Related]
6. Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout.
Dalbeth N; House ME; Horne A; Petrie KJ; McQueen FM; Taylor WJ
BMC Musculoskelet Disord; 2012 Sep; 13():174. PubMed ID: 22978848
[TBL] [Abstract][Full Text] [Related]
7. Inpatient management of gout in a New Zealand hospital: a retrospective audit.
Kennedy NJ; Healy PJ; Harrison AA
Int J Rheum Dis; 2016 Feb; 19(2):205-10. PubMed ID: 25873399
[TBL] [Abstract][Full Text] [Related]
8. Management of gout by Moroccan rheumatologists: a Moroccan Society for Rheumatology National Survey.
Moulay Berkchi J; Rkain H; Benbrahim L; Aktaou S; Lazrak N; Faiz S; Ahid S; Abouqal R; Labzizi S; Ouzeddoun N; Oukerraj L; Hmamouchi I; Hajjaj-Hassouni N; Allali F
Rheumatol Int; 2020 Sep; 40(9):1399-1408. PubMed ID: 32447422
[TBL] [Abstract][Full Text] [Related]
9. Better outcomes for patients with gout.
Day R; Nguyen A; Graham G; Aung E; Coleshill M; Stocker S
Inflammopharmacology; 2020 Oct; 28(5):1395-1400. PubMed ID: 32095979
[TBL] [Abstract][Full Text] [Related]
10. Preventing attacks of acute gout when introducing urate-lowering therapy: a systematic literature review.
Seth R; Kydd AS; Falzon L; Bombardier C; van der Heijde DM; Edwards CJ
J Rheumatol Suppl; 2014 Sep; 92():42-7. PubMed ID: 25180127
[TBL] [Abstract][Full Text] [Related]
11. The management of gout at an academic healthcare center in Beijing: a physician survey.
Fang W; Zeng X; Li M; Chen LX; Schumacher HR; Zhang F
J Rheumatol; 2006 Oct; 33(10):2041-9. PubMed ID: 17014019
[TBL] [Abstract][Full Text] [Related]
12. Comparative Risk of Gout Flares When Initiating or Escalating Various Urate-Lowering Therapy: A Systematic Review With Network Meta-Analysis.
Maher D; Reeve E; Hopkins A; Tan JM; Tantiongco M; Ailabouni N; Woodman R; Stamp L; Bursill D; Proudman S; Wiese M
Arthritis Care Res (Hoboken); 2024 Jun; 76(6):871-881. PubMed ID: 38303574
[TBL] [Abstract][Full Text] [Related]
13. Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists.
Vargas-Santos AB; Castelar-Pinheiro Gda R; Coutinho ES; Schumacher HR; Singh JA; Schlesinger N
PLoS One; 2015; 10(8):e0135805. PubMed ID: 26274585
[TBL] [Abstract][Full Text] [Related]
14. Casebook consults: improving outcomes in gout (multimedia activity).
Doghramji PP; Mandell BF; Pope RS
Am J Med; 2012 Aug; 125(8):S1. PubMed ID: 22840678
[TBL] [Abstract][Full Text] [Related]
15. A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout.
Richardson JC; Liddle J; Mallen CD; Roddy E; Hider S; Prinjha S; Ziebland S
BMC Musculoskelet Disord; 2016 Jun; 17():249. PubMed ID: 27267878
[TBL] [Abstract][Full Text] [Related]
16. Management of gout by UK rheumatologists: a British Society for Rheumatology national audit.
Roddy E; Packham J; Obrenovic K; Rivett A; Ledingham JM
Rheumatology (Oxford); 2018 May; 57(5):826-830. PubMed ID: 29447370
[TBL] [Abstract][Full Text] [Related]
17. Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practice.
Spaetgens B; Pustjens T; Scheepers LEJM; Janssens HJEM; van der Linden S; Boonen A
Clin Rheumatol; 2016 Aug; 35(8):2053-2061. PubMed ID: 26898982
[TBL] [Abstract][Full Text] [Related]
18. Pharmacist-managed titration of urate-lowering therapy to streamline gout management.
Huang IJ; Liew JW; Morcos MB; Zuo S; Crawford C; Bays AM
Rheumatol Int; 2019 Sep; 39(9):1637-1641. PubMed ID: 31147732
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare.
Janssen CA; Oude Voshaar MAH; Ten Klooster PM; Vonkeman HE; van de Laar MAFJ
Clin Rheumatol; 2019 Aug; 38(8):2233-2239. PubMed ID: 31030363
[TBL] [Abstract][Full Text] [Related]
20. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
